In this conference update video, hepatologist Prof. Dr Peter R. Galle joins us live from ASCO 2024 to discuss new hepatocellular carcinoma (HCC) clinical trial data from CheckMate 9DW and share his insights into the potential implications for clinical practice.

 

What could these developments mean for the treatment landscape in HCC?

 

ASCO 2024 selected HCC abstract

  • Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable HCC: First results from CheckMate 9DW.
    Galle PR, et al.
    Abstract LBA4008, ASCO 2024

Programme summary
  • clock Duration 1 MIN
  • clock Language(s) flag
Watch the video now
Other episodes in this series
ASCO 2024 lung cancer highlights

ASCO 2024 lung cancer highlights

A conference update on lung cancer clinical trial data from ASCO

ASCO 2024 breast cancer highlights

ASCO 2024 breast cancer highlights

How could the data impact clinical practice?

ASCO 2024 HCC highlights

ASCO 2024 HCC highlights

How could the latest clinical trial data impact the management of hepatocellular carcinoma?

Current Episode
ASCO 2024 upper GI cancer highlights

ASCO 2024 upper GI cancer highlights

Practice-changing upper GI trial data direct from ASCO 2024

Share this programme
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

Conference update
Oncology 
Oncogene-addicted NSCLC: Highlights from ASCO 2024

The latest non-small cell lung cancer data presented at ASCO

Experts
Prof. Nicolas Girard
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Upper lower GI cancer update ASCO 2024 Conference update
Oncology 
Upper and lower GI cancer update from ASCO 2024

GI oncologists review the latest data presented at ASCO 2024

Experts
Dr Samuel J Klempner, Dr Elizabeth Smyth, Prof. Jenny Seligmann, Dr Dominik Modest
  • clock 8 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Experts Knowledge Share Video
Oncology Hemato-oncology 
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)

Medical experts discuss the latest learnings from clinical practice

Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter
  • download Downloadable
    Resources
  • clock 76 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Menarini Stemline Oncology.
Conference update

Episode

1

of 4

episode
Oncology 
ASCO 2024 lung cancer highlights

A conference update on lung cancer clinical trial data from ASCO

Experts
Prof. Mark Socinski
  • clock 4 MIN
  • calendar Jun 2024

Conference update

Episode

2

of 4

episode
Oncology 
ASCO 2024 breast cancer highlights

How could the data impact clinical practice?

Experts
Prof. Shaheenah Dawood
  • clock 3 MIN
  • calendar Jun 2024

Conference update

Episode

4

of 4

episode
Oncology 
ASCO 2024 upper GI cancer highlights

Practice-changing upper GI trial data direct from ASCO 2024

Experts
Dr Samuel J Klempner, Dr Elizabeth Smyth
  • clock 3 MIN
  • calendar Jun 2024

This educational programme is supported by an Independent Medical Education Grant from Bayer.